Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1533 ARTÍCULOS , VIENDO DEL 1501 AL 1515

Transcranial direct current stimulation can enhance working memory in Huntington's disease

Eddy CM, Shapiro K, Clouter A, Hansen PC, Rickards HE.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Jul 3;77:75-82. doi: 10.1016/j.pnpbp.2017.04.002. Epub 2017 Apr 5.

Ultra-Early Phase pathologies of Alzheimer's disease and other neurodegenerative diseases

Okazawa H.

Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(6):361-377. doi: 10.2183/pjab.93.022.

Neuroglia: Functional Paralysis and Reactivity in Alzheimer's Disease and Other Neurodegenerative Pathologies

Verkhratsky A, Zorec R, Rodriguez JJ, Parpura V.

Adv Neurobiol. 2017;15:427-449. doi: 10.1007/978-3-319-57193-5_17.

Nonmotor Symptoms in Huntington Disease

Cardoso F.

Int Rev Neurobiol. 2017;134:1397-1408. doi: 10.1016/bs.irn.2017.05.004. Epub 2017 Jun 1.

Globular glial tauopathy presenting as non-fluent/agrammatic variant primary progressive aphasia with chorea

Kim EJ, Lee MJ, Lee JH, Lee YM, Shin JH, Shin MJ, Choi KU, Jung NY, Pak K, Hwang C, Ahn JW, Sung S, Spina S, Grinberg LT, Seeley WW, Huh GY.

Parkinsonism Relat Disord. 2017 Nov;44:159-161. doi: 10.1016/j.parkreldis.2017.09.006. Epub 2017 Sep 6.

The impact of Huntington disease on young people

Ellison M.

Handb Clin Neurol. 2017;144:179-182. doi: 10.1016/B978-0-12-801893-4.00015-8.

Motor, cognitive, and functional declines contribute to a single progressive factor in early HD

Schobel SA, Palermo G, Auinger P, Long JD, Ma S, Khwaja OS, Trundell D, Cudkowicz M, Hersch S, Sampaio C, Dorsey ER, Leavitt BR, Kieburtz KD, Sevigny JJ, Langbehn DR, Tabrizi SJ; TRACK-HD, COHORT, CARE-HD, and 2CARE Huntington Study Group Investigators.

Neurology. 2017 Dec 12;89(24):2495-2502. doi: 10.1212/WNL.0000000000004743. Epub 2017 Nov 15.

Quantitative modeling of category learning deficits in various patient populations

Filoteo JV, Maddox WT, Ashby FG.

Neuropsychology. 2017 Nov;31(8):862-876. doi: 10.1037/neu0000422.

Caspr2 antibodies in a patient with prostate cancer: a cognitive deterioration with recurrent and paroxysmal gait ataxia and aphasia

Sousa S, Guerreiro R, Carmona C, Gouveia LO, Pita F.

Neurol Sci. 2017 Dec;38(12):2217-2219. doi: 10.1007/s10072-017-3072-9. Epub 2017 Aug 4.

An Unusual Presentation of Creutzfeldt-Jakob Disease and an Example of How Hickam's Dictum and Ockham's Razor Can Both Be Right

Neiman ES, Farheen A, Gadallah N, Steineke T, Parsells P, Kizelnik ZA, Rosenberg M.

Neurodiagn J. 2017;57(3):234-239. doi: 10.1080/21646821.2017.1348767.

Towards defining restlessness in individuals with dementia

Regier NG, Gitlin LN.

Aging Ment Health. 2017 May;21(5):543-552. doi: 10.1080/13607863.2015.1128880. Epub 2016 Jan 8.

Neurotransmitter release: vacuolar ATPase V0 sector c-subunits in possible gene or cell therapies for Parkinson's, Alzheimer's, and psychiatric diseases

Higashida H, Yokoyama S, Tsuji C, Muramatsu SI.

J Physiol Sci. 2017 Jan;67(1):11-17. doi: 10.1007/s12576-016-0462-3. Epub 2016 Jun 11.

Similarity of symptoms between transient epileptic amnesia and Lewy body disease

Ukai K, Fujishiro H, Watanabe M, Kosaka K, Ozaki N.

Psychogeriatrics. 2017 Mar;17(2):120-125. doi: 10.1111/psyg.12199. Epub 2016 Jun 30.

Parkin loss-of-function pathology: Premature neuronal senescence induced by high levels of reactive oxygen species?

Buhlman LM.

Mech Ageing Dev. 2017 Jan;161(Pt A):112-120. doi: 10.1016/j.mad.2016.06.008. Epub 2016 Jun 29.

An overview of circulating cell-free microRNAs as putative biomarkers in Alzheimer's and Parkinson's Diseases

Batistela MS, Josviak ND, Sulzbach CD, de Souza RL.

Int J Neurosci. 2017 Jun;127(6):547-558. doi: 10.1080/00207454.2016.1209754. Epub 2016 Jul 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias